Scienture Holdings SCNX
NASDAQ SCNX
$2.89 -0.16 (-5.19%)
As of: Oct 21, 2026 · 12:50 PM EDT

Scienture Holdings (SCNX) Work In Process (2022)

Updated

Scienture Holdings' Work In Process came in at $875,321 for Q2 2022.

Analysis

Scienture Holdings (SCNX) Work In Process (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn
10 Scienture Holdings 4.57 Mn -12.34 Mn 335,779.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 875,321.00
API Access

Scienture Holdings Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=SCNX&period=max&api_key=YOUR_API_KEY